PHIEGO PHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PHIEGO PHARMA
Largest movements
- Tangible fixed assets -€16,250
down €16,250 (-4.4%), from €369,350 to €353,100
of which Land and buildings: -€16,318
- Cash +€11,309
up €11,309 (+83.5%), from €13,538 to €24,847
mainly Net result for the year (+€34,861) and Depreciation (+€16,961)
- Debts after one year -€27,501
down €27,501 (-10.3%), from €266,776 to €239,275
- Reserves +€17,861
up €17,861 (+18.5%), from €96,489 to €114,349
- Short-term financial debts +€4,051
new in 2025: €4,051
- Gross operating margin +€23,990
up €23,990 (+50.7%), from €47,285 to €71,274
- Taxes +€4,450
up €4,450 (+78.9%), from €5,639 to €10,089
- Staff costs -€1,935
no longer reported in 2025 (was €1,935)
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €403,719 | €400,654 | -€3,066 | -0.8% |
| Fixed assets | 21/28 | €369,350 | €353,100 | -€16,250 | -4.4% |
| Tangible fixed assets | 22/27 | €369,350 | €353,100 | -€16,250 | -4.4% |
| Land and buildings | 22 | €367,919 | €351,601 | -€16,318 | -4.4% |
| Furniture and vehicles | 24 | €1,431 | €1,499 | +€68 | +4.8% |
| Current assets | 29/58 | €34,369 | €47,553 | +€13,184 | +38.4% |
| Amounts receivable within one year | 40/41 | €17,982 | €19,822 | +€1,840 | +10.2% |
| Trade receivables | 40 | €10,931 | €16,691 | +€5,760 | +52.7% |
| Other amounts receivable | 41 | €7,051 | €3,131 | -€3,920 | -55.6% |
| Cash at bank and in hand | 54/58 | €13,538 | €24,847 | +€11,309 | +83.5% |
| Deferred charges and accrued income | 490/1 | €2,849 | €2,885 | +€35 | +1.2% |
| Total equity and liabilities | 10/49 | €403,719 | €400,654 | -€3,066 | -0.8% |
| Equity | 10/15 | €101,489 | €119,349 | +€17,861 | +17.6% |
| Contributions | 10/11 | €5,000 | €5,000 | = | 0.0% |
| Reserves | 13 | €96,489 | €114,349 | +€17,861 | +18.5% |
| Distributable reserves | 133 | €96,489 | €114,349 | +€17,861 | +18.5% |
| Amounts payable | 17/49 | €302,231 | €281,305 | -€20,926 | -6.9% |
| Amounts payable after more than one year | 17 | €266,776 | €239,275 | -€27,501 | -10.3% |
| Financial debts | 170/4 | €266,776 | €239,275 | -€27,501 | -10.3% |
| Amounts payable within one year | 42/48 | €35,455 | €42,029 | +€6,575 | +18.5% |
| Current portion of amounts payable after more than one year | 42 | €27,330 | €27,501 | +€170 | +0.6% |
| Financial debts | 43 | - | €4,051 | +€4,051 | |
| Credit institutions | 430/8 | - | €4,051 | +€4,051 | |
| Trade debts | 44 | €496 | €1,416 | +€920 | +186% |
| Suppliers | 440/4 | €496 | €1,416 | +€920 | +186% |
| Taxes, remuneration and social security | 45 | €7,628 | €9,061 | +€1,433 | +18.8% |
| Taxes | 450/3 | €7,628 | €9,061 | +€1,433 | +18.8% |
| Remuneration, social security and pensions | 62 | €1,935 | - | -€1,935 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €16,874 | €16,961 | +€87 | +0.5% |
| Other operating charges | 640/8 | €2,875 | €2,623 | -€252 | -8.8% |
| Gross operating margin | 9900 | €47,285 | €71,274 | +€23,990 | +50.7% |
| Operating profit (loss) | 9901 | €25,600 | €51,691 | +€26,091 | +102% |
| Financial income | 75/76B | €16 | €52 | +€36 | +227% |
| Recurring financial income | 75 | €16 | €52 | +€36 | +227% |
| Financial charges | 65/66B | €7,382 | €6,793 | -€589 | -8.0% |
| Recurring financial charges | 65 | €7,382 | €6,793 | -€589 | -8.0% |
| Profit (loss) for the period before taxes | 9903 | €18,234 | €44,950 | +€26,715 | +147% |
| Income taxes | 67/77 | €5,639 | €10,089 | +€4,450 | +78.9% |
| Profit (loss) for the period | 9904 | €12,595 | €34,861 | +€22,266 | +177% |
| Profit (loss) for the period to be appropriated | 9905 | €12,595 | €34,861 | +€22,266 | +177% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 24 October 2026 via checked.be.